A Registry Study on Genetics and Biomarkers of Thoracic Aortic Aneurysm/Dissection

Last updated: January 3, 2017
Sponsor: Beijing Institute of Heart, Lung and Blood Vessel Diseases
Overall Status: Trial Status Unknown

Phase

N/A

Condition

Heart Disease

Aneurysm

Cardiovascular Disease

Treatment

N/A

Clinical Study ID

NCT03010514
BeijingIHLBVD2016017
  • Ages < 80
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

This is a national registry study to determine genetic risk factor and serial biomarkers of thoracic aortic aneurysm/dissection

Eligibility Criteria

Inclusion

Case Inclusion Criteria:

  1. Subject who was diagnosed as thoracic aortic aneurysm/dissection by CT angiography,interventional angiography or vascular ultrasound;

  2. Age is less than 80 years old;

  3. male and non pregnancy female;

  4. Subject understands study requirements aand agrees to sign an informed consent formprior to any study procedures.

Exclusion

Case Exclusion Criteria: Subject has one of the following:

  1. Pseudoaneurysm;

  2. Previous infection or trauma in the damaged part of aorta;

  3. Pregnancy female;

  4. Participate in other clinical trials in the last 1 months. Control Inclusion Criteria:

  5. Age and gender are matched with cases;

  6. No aortic disease was detected by outpatient ultrasound;

  7. No family history of cardiovascular disease;

  8. Normal biochemical indicators; Criteria for culling, shedding and suspension testing:

  9. Culling: Unqualified cases and controls. Data of culled subjects can not be used forstatistical analysis;

  10. Shedding: Subject that self withdrawal, loss to follow-up, or quitted by doctors;Reasons for shedding should be indicated for each shed subject.

  11. Suspension: a) The researchers found significant safety problems or wrong studydesign; b) Researchers cannot continue clinical research due to funding or managementreasons; c) Director ends the study. When suspension happens, all the CRF table shouldbe reserved for future reference.

Study Design

Total Participants: 600
Study Start date:
October 01, 2016
Estimated Completion Date:
October 31, 2019

Connect with a study center

  • Beijing Anzhen Hospital

    Beijing, 100029
    China

    Active - Recruiting

Map preview placeholder

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.